908 Devices’ (MASS) Sell (E+) Rating Reiterated at Weiss Ratings

Weiss Ratings reaffirmed their sell (e+) rating on shares of 908 Devices (NASDAQ:MASS) in a report released on Saturday,Weiss Ratings reports.

Separately, Stephens reiterated an “overweight” rating and issued a $6.00 target price on shares of 908 Devices in a research report on Wednesday, January 15th. Two analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $5.33.

908 Devices Price Performance

Shares of 908 Devices stock opened at $4.24 on Friday. 908 Devices has a 1 year low of $1.81 and a 1 year high of $7.56. The firm has a market cap of $149.80 million, a PE ratio of -2.40 and a beta of 0.99. The company has a 50 day simple moving average of $2.96 and a two-hundred day simple moving average of $2.93.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of MASS. Two Sigma Advisers LP bought a new stake in shares of 908 Devices in the 4th quarter worth approximately $30,000. Prudential Financial Inc. bought a new stake in 908 Devices in the fourth quarter worth $34,000. Occudo Quantitative Strategies LP purchased a new stake in 908 Devices during the fourth quarter valued at about $36,000. Two Sigma Investments LP bought a new position in shares of 908 Devices during the fourth quarter valued at about $42,000. Finally, B. Riley Wealth Advisors Inc. bought a new position in shares of 908 Devices during the third quarter valued at about $45,000. 88.06% of the stock is currently owned by institutional investors.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.